Skip to main content

Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia

Abstract

The aim of this study is to measure serum levels of neurotropic factor (NF) in patients with dementia. Brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and neurotrophin-3 (NT-3) were determined in Alzheimer’s dementia patients without medication (AD; n: 22), Alzheimer’s dementia patients receiving cholinesterase inhibitor (CEI) treatment (AD + CEI; n: 32) and vascular dementia patients receiving CEI treatment (VaD + CEI; n: 27) and the age-matched control group (n: 20). NGF levels were detected to be significantly higher in the control group than in AD group (P < 0.001). BDNF and NT-3 levels in AD group were not significantly different from control group’s levels. NGF levels in AD + CEI group were significantly higher than in AD group (P < 0.05). There was also no significant difference in serum neurotrophic factor levels between AD + CEI and VaD + CEI group. A positive correlation between BDNF and Mini Mental State Examination (MMSE) scores (r: 0.422, P < 0.01) in AD group and a negative correlation between BDNF and MMSE scores in the AD + CEI group (r: −0.357, P < 0.005) were obtained. In conclusion, our results suggest that while serum NGF levels are associated with the presence of dementia, serum BDNF levels may be associated with the severity of Alzheimer’s dementia. However, future studies are required to determine the importance of NFs.

This is a preview of subscription content, access via your institution.

References

  1. Grossman H, Bergmann C, Parker S (2006) Dementia: a brief review. Mt Sinai J Med 73(7):985–992

    PubMed  Google Scholar 

  2. Maccioni RB, Muñoz JP, Barbeito L (2001) The molecular bases of Alzheimer’s disease and other neurodegenerative disorders. Arch Med Res 32:367–371

    PubMed  Article  CAS  Google Scholar 

  3. Good PF, Werner P, Hsu A, Olanow CW, Perl DP (1996) Evidence of neuronal oxidative damage in Alzheimer’s disease. Am J Pathol 149:21–28

    PubMed  CAS  Google Scholar 

  4. Perry G, Taddeo MA, Nunomura A, Zhu X, Zenteno-Savin T et al (2002) Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response. Comp Biochem Physiol 133:507–513

    Google Scholar 

  5. Dugué M, Neugroschl J, Sewell M, Marin D (2003) Review of dementia. Mt Sinai J Med 70:45–53

    Google Scholar 

  6. Mattson MP, Chan SL, Duan W (2002) Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev 82:637–672

    PubMed  CAS  Google Scholar 

  7. Schulte-Herbrüggen O, Jockers-Scherübl MC, Hellweg R (2008) Neurotrophins: from pathophysiology to treatment in Alzheimer’s disease. Curr Alzheimer Res 5:38–44

    PubMed  Article  Google Scholar 

  8. McKhann G, Drachman D, Folstein M, Katzman R, Price D et al (1984) Clinical diagnosis of Alzheimer’s disease-report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34:939–944

    PubMed  Article  CAS  Google Scholar 

  9. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250–260

    PubMed  Article  CAS  Google Scholar 

  10. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental-State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    PubMed  Article  CAS  Google Scholar 

  11. Alderson RF, Alterman AL, Barde YA, Lindsay RM (1991) Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurones in culture. Neuron 5:297–306

    Article  Google Scholar 

  12. Schindowski K, Belarbi K, Buée L (2008) Neurotrophic factors in Alzheimer’s disease: role of axonal transport. Genes Brain Behav 7:43–56

    PubMed  Article  CAS  Google Scholar 

  13. Royo NC, Conte V, Saatman KE, Shimizu S, Belfield CM et al (2006) Hippocampal vulnerability following traumatic brain injury: a potential role for neurotrophin-4/5 in pyramidal cell neuroprotection. Eur J Neurosci 23(5):1089–1102

    PubMed  Article  CAS  Google Scholar 

  14. Karege F, Schwald M, Cisse M (2002) Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 16; 328(3):261–264

    Google Scholar 

  15. Durany N, Michel T, Kurt J, Cruz-Sánchez FF, Cervás-Navarro J et al (2000) Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer’s disease brains. Int J Dev Neurosci 18:807–813

    Article  CAS  Google Scholar 

  16. Hock C, Heese K, Hulette C, Rosenberg C, Otten U (2000) Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57:846–851

    PubMed  Article  CAS  Google Scholar 

  17. Ziegenhorn AA, Schulte-Herbrüggen O, Danker-Hopfe H, Malbranc M, Hartung HD et al (2007) Serum neurotrophins—a study on the time course and influencing factors in a large old age sample. Neurobiol Aging 28:1436–1445

    PubMed  Article  CAS  Google Scholar 

  18. Yasutake C, Kuroda K, Yanagawa T, Okamura T, Yoneda H, Serum BDNF (2006) TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer’s disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci 256:402–406

    PubMed  Article  Google Scholar 

  19. Laske C, Stransky E, Leyhe T, Eschweiler GW, Wittorf A et al (2006) Stage-dependent BDNF serum concentrations in Alzheimer’s disease. J Neural Transm 113:1217–1224

    PubMed  Article  CAS  Google Scholar 

  20. Laske C, Stransky E, Leyhe T, Eschweiler GW, Maetzler W et al (2007) BDNF serum and CSF concentrations in Alzheimer’s disease, normal pressure hydrocephalus and healthy controls. J Psychiatr Res 41:387–394

    PubMed  Article  Google Scholar 

  21. Miyake K, Yamamoto W, Tadokoro M (2002) Alterations in hippocampal GAP-43, BDNF, and L1 following sustained cerebral ischemia. Brain Res 935:24–31

    PubMed  Article  CAS  Google Scholar 

  22. Lindvall O, Ernfors P, Bengzon J (1992) Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci USA 89:648–652

    PubMed  Article  CAS  Google Scholar 

  23. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J et al (2000) Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 470:113–117

    PubMed  Article  CAS  Google Scholar 

  24. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C et al (2005) The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26:115–123

    PubMed  Article  CAS  Google Scholar 

  25. Wang J, Zhang HY, Tang XC (2009) Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment. Acta Pharmacol Sin 30:879–888

    PubMed  Article  CAS  Google Scholar 

  26. Leyhe T, Stransky E, Eschweiler GW, Buchkremer G, Laske C (2008) Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer’s disease. Eur Arch Psychiatry Clin Neurosci 258:24–28

    Article  Google Scholar 

  27. Darreh-Shori T, Soininen H (2010) Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer’s disease: a review of recent clinical studies. Curr Alzheimer Res 7(1):67–73

    PubMed  Article  CAS  Google Scholar 

  28. Winter B, Breitenstein C, Mooren FC, Voelker K, Fobker M et al (2007) High impact running improves learning. Neurobiol Learn Mem 87:597–609

    PubMed  Article  Google Scholar 

  29. Lee HY, Kim YK (2008) Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 57:194–199

    PubMed  Article  CAS  Google Scholar 

  30. Lad SP, Neet KE, Mufson EJ (2003) Nerve growth factor: structure, function and therapeutic implications for Alzheimer’s disease. Curr Drug Targets CNS Neurol Disord 2:315–334

    PubMed  Article  CAS  Google Scholar 

  31. Murase K, Nabeshima T, Robitaille Y, Quirion R, Ogawa M, Hayashi K (1993) NGF level of is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer’s disease. Biochem Biophys Res Commun 193:198–203

    PubMed  Article  CAS  Google Scholar 

  32. Schaub RT, Anders D, Golz G, Göhringer K, Hellweg R (2002) Serum nerve growth factor concentration and its role in the preclinical stage of dementia. Am J Psychiatry 159:1227–1229

    PubMed  Article  Google Scholar 

  33. Narisawa-Saito M, Nawa H (1996) Differential regulation of hippocampal neurotrophins during aging in rats. J Neurochem 67:1124–1131

    PubMed  Article  CAS  Google Scholar 

  34. Chao MV, Rajagopal R, Lee FS (2006) Neurotrophin signalling in health and disease. Clin Sci (Lond) 110:167–173

    Article  CAS  Google Scholar 

  35. Pan W, Banks WA, Kastin AJ (1998) Permeability of the blood–brain barrier to neurotrophins. Brain Res 788:87–94

    PubMed  Article  CAS  Google Scholar 

  36. Walz JC, Andreazza AC, Frey BN, Cacilhas AA, Ceresér KM et al (2007) Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neurosci Lett 19:87–89

    Article  Google Scholar 

  37. Nemoto K, Ohnishi T, Mori T et al (2006) The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett 397:25–29

    PubMed  Article  CAS  Google Scholar 

  38. Colcombe SJ, Kramer AF, McAuley E, Erickson KI, Scalf P (2004) Neurocognitive aging and cardiovascular fitness: recent findings and future directions. J Mol Neurosci 24:9–14

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by The Research Fund of Istanbul University (Project Number: 2578, UDP-24348).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dildar Konukoglu.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Konukoglu, D., Andican, G., Fırtına, S. et al. Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia. Acta Neurol Belg 112, 255–260 (2012). https://doi.org/10.1007/s13760-012-0101-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-012-0101-6

Keywords

  • Alzheimer’s disease
  • Brain-derived neurotrophic factor
  • Dementia
  • Neurotropic factor
  • Nerve growth factor
  • Neurotrophin-3